1. Home
  2. SLDB vs WGO Comparison

SLDB vs WGO Comparison

Compare SLDB & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$6.86

Market Cap

781.7M

Sector

Health Care

ML Signal

N/A

Logo Winnebago Industries Inc.

WGO

Winnebago Industries Inc.

N/A

Current Price

$23.35

Market Cap

743.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SLDB
WGO
Founded
2013
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
781.7M
743.5M
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
SLDB
WGO
Price
$6.86
$23.35
Analyst Decision
Strong Buy
Buy
Analyst Count
13
14
Target Price
$18.62
★ $37.80
AVG Volume (30 Days)
★ 1.2M
597.2K
Earning Date
11-02-2026
10-21-2026
Dividend Yield
N/A
★ 5.84%
EPS Growth
34.97
★ 106.82
EPS
N/A
★ 0.87
Revenue
$8,094,000.00
★ $1,985,674,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.36
P/E Ratio
★ N/A
$28.33
Revenue Growth
N/A
★ N/A
52 Week Low
$3.79
$24.13
52 Week High
$11.45
$50.16

Technical Indicators

Market Signals
Indicator
SLDB
WGO
Relative Strength Index (RSI) 29.65 23.92
Support Level $6.76 N/A
Resistance Level $7.26 $30.90
Average True Range (ATR) 0.39 0.84
MACD -0.06 -0.20
Stochastic Oscillator 9.05 0.00

Price Performance

Historical Comparison
SLDB
WGO

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was $2.8 billion in fiscal 2025. Winnebago expanded into towables in 2010 with the acquisition of SunnyBrook and acquired Grand Design in 2016. Towables made up 84% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total fiscal 2025 RV unit volume was 36,911. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in 2019, and acquired Barletta pontoon boats in 2021. It also is developing electric and autonomous technology.

Share on Social Networks: